510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

HydroMARK Breast Biopsy Site Marker

K210752510(k) SpecialCleared Apr 14, 202130-day reviewClass II21 CFR 878.4300Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Devicor Medical Products, Inc. · NEU Marker, Radiographic, Implantable

Cleared on Apr 14, 2021 as substantially equivalent to K121113 (Biopsy Sciences, LLC, 2012) after a 30-day review. Its family tree reaches back 7 generations to 2003. 5 later devices descend from it. It has been recalled once.

Decided
Apr 14, 2021
Review
30 days
Class
Class II
Product code
NEU
Recalls
1
Predicates
1

Its longest line of descent runs back 7 generations to K023694 (2003). 9 ancestors in all, the oldest K970817 (1997). 5 later devices descend from it, 1 citing it directly.

  1. Root · 7 generations backK023694 Bio-Mark Resorbable Biopsy Site Marker and Bio-Mark Permanent Biopsy…Biopsy Sciences, LLC · 2003
  2. 6 generations backK051421 Inter V Brand V-Mark Breast Biopsy Site Marker with Titanium AnchorMedical Device Technologies, Inc. · 2005
  3. 5 generations backK053518 Interv Brand V-Mark Breast Biopsy Site Marker with Titanium AnchorMedical Device Technologies, Inc. · 2006
  4. 4 generations backK060769 Hydromark Biopsy Site MarkerBiopsy Sciences, LLC · 2006
  5. 3 generations backK083006 Biopsy Sciences, Inc., Hydromark Breast Biopsy Site MarkerBiopsy Sciences, LLC · 2009
  6. 2 generations backK090501 Biopsy Sciences Hydromark Breast Biopsy Site Marker, Models…Biopsy Sciences, LLC · 2009
  7. 1 generation backK121113 Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 2012
  8. This deviceK210752 HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 2021
  9. Descendant · cites it directly · 4 of its ownK212158 HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 2022 · Recalled
  10. Descendant · 2 generations on · 2 of its ownK221961 HydroMARK Plus Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 2023
  11. Descendant · 3 generations on · 0 of its ownK253761 HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape)…Devicor Medical Products, Inc. · 2026
  12. Descendant · 3 generations on · 0 of its ownK240527 HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird Shape)…Devicor Medical Products, Inc. · 2024
  13. Descendant · 2 generations on · 0 of its ownK232615 LumiMARK™ Biopsy Site Marker (LM0215T (Tulip Shape)); LumiMARK™…Devicor Medical Products, Inc. · 2024

Most influential descendants

Showing 5 of 5 · See all
  • K212158HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 2022 · cites it directly4descendants
  • K221961HydroMARK Plus Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 2023 · 2 generations on2descendants
  • K253761HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK™ Plus Breast…Devicor Medical Products, Inc. · 2026 · 3 generations on0descendants
  • K240527HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird Shape) (4010-02-15-T6)Devicor Medical Products, Inc. · 2024 · 3 generations on0descendants
  • K232615LumiMARK™ Biopsy Site Marker (LM0215T (Tulip Shape)); LumiMARK™ Biopsy Site Marker…Devicor Medical Products, Inc. · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K023694Bio-Mark Resorbable Biopsy Site Marker and Bio-Mark Permanent Biopsy Site MarkerBiopsy Sciences, LLC2003—
−6K051421Inter V Brand V-Mark Breast Biopsy Site Marker with Titanium AnchorMedical Device Technologies, Inc.2005—
−5K053518Interv Brand V-Mark Breast Biopsy Site Marker with Titanium AnchorMedical Device Technologies, Inc.2006—
−4K060769Hydromark Biopsy Site MarkerBiopsy Sciences, LLC2006—
−3K083006Biopsy Sciences, Inc., Hydromark Breast Biopsy Site MarkerBiopsy Sciences, LLC2009—
−2K090501Biopsy Sciences Hydromark Breast Biopsy Site Marker, Models 4005-02-15-T1…Biopsy Sciences, LLC2009—
−1K121113Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC2012—
0 (this device)K210752HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc.2021—
+1K212158HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc.20221
+2K221961HydroMARK Plus Breast Biopsy Site MarkerDevicor Medical Products, Inc.2023—
+3K253761HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK™ Plus…Devicor Medical Products, Inc.2026—
+3K240527HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird Shape) (4010-02-15-T6)Devicor Medical Products, Inc.2024—
+2K232615LumiMARK™ Biopsy Site Marker (LM0215T (Tulip Shape)); LumiMARK™ Biopsy Site…Devicor Medical Products, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202310
202420
202610
FIG. 1 — Lineage of K210752, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NEU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NEU device

  1. #1 K240042 MOLLI 2 Systemscore 14.4 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121113Biopsy Sciences, Inc. Hydromark Brest Biosy Site Marker
Summary page 5
…K210752 Page 2 of 7 * Devicor Medical Products Inc. HydroMARK Breast Biopsy Site Marker (K121113) [predicate device] * Devicor Medical Products Inc. HydroMARK Breast Biopsy Site Marker Predicate…
Biopsy Sciences, LLC2012—
†K130537Biopsy Sciences LLC Hydromark Breast Biopsy Site MarkerBiopsy Sciences, LLC2013—
†K161021HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc.2016—

Also cleared against K121113: 2 other devices →

What descends from it? (5)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K212158HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc.20224

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 30, 2022Class IIZ-1124-2022Labeling Change ControlSmall patient labels do not match the primary device label. The primary device label accurately identifies the product as 4010-05-08-T4, while the smaller patient label incorrectly identifies the product as 4010-05-08-T3.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 2.5 years on median.
  • None of the 9 ancestors has a recall.
  • Of its descendants, K212158 (Devicor Medical Products, Inc., 2022) has gone furthest, with 4 descendants of its own.
  • 2 other devices also cite its predicate K121113.

How does its category compare?

All NEU devices

NEU Marker, Radiographic, Implantable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · NEU

5in 2025

2007: 42008: 72009: 42010: 52011: 32012: 32013: 72014: 32015: 72016: 22017: 42018: 82019: 52020: 32021: 32022: 22023: 42024: 102025: 52026 (partial year): 1
2007high 10 (2024) · low 2 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NEU

99in 2025

2007: 94 days median2008: 107 days median2009: 70 days median2010: 69 days median2011: 145 days median2012: 120 days median2013: 49 days median2014: 48 days median2015: 111 days median2017: 115 days median2018: 89 days median2019: 149 days median2020: 169 days median2021: 46 days median2023: 136 days median2024: 267 days median2025: 99 days median
2007high 267 (2024) · low 46 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NEU

2in 2025

2011: 12017: 12022: 12024: 2, 1 Class I2025: 22026 (partial year): 2
2007high 2 (2024) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · NEU

411in 2025

2007: 52008: 52009: 302010: 122011: 182012: 542013: 602014: 382015: 1202016: 562017: 692018: 662019: 582020: 452021: 822022: 1002023: 1422024: 2472025: 411
2007high 411 (2025) · low 5 (2007)2025

MAUDE reports naming product code NEU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200749405
2008710705
2009470030
2010569012
20113145118
20123120054
2013749060
2014348038
201571110120
20162—056
20174115169
2018889066
20195149058
20203169045
2021346082
20222—1100
202341360142
2024102672 (1)247
20255992411
20261—2—

What is it indicated for?

The HydroMARK Breast Biopsy Site Marker is intended to mark tissue during a percutaneous breast biopsy procedure, be visible under ultrasound for at least 6 weeks, and be permanently visible by x-ray and MRI.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K210752: HydroMARK Breast Biopsy Site Marker.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K210752

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026